Navidea Biopharmaceuticals, Inc. (NAVB) Social Stream



Navidea Biopharmaceuticals, Inc. (NAVB): $0.67

-0.06 (-7.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NAVB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 493

in industry

Featured Post From StockTwits About NAVB

$NAVB New SEC Filing: 8-K Earnings - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) August 11


Item 2.02 Results of Operations and Financial Condition. On August 11, 2021, Navidea Biopharmaceuticals, Inc. (the "Company") issued a press release regarding its consolidated financial results for the quarter and year-to-date ended June 30, 2021. A copy of the Company's August 11, 2021 press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 2.02 of this Current Report on Form 8-K, including exhibit 99.1 attached hereto, shall not be treated as "filed" for purposes of the Securities Exchange Act of 1934, as amended. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit (...)

https://mkn.re/95078
MarketNewswire, published August 11, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5561 seconds.